Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Centessa Pharmaceuticals plc

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Dec-31-20
   10-Q10-Q10-Q10-Q8-K10-Q10-Q10-K
Revenues  0.00.00.0-2.041.50.0-11.30.0
            Revenue growth   -100.0%-100.0%   -704.6% 
Cost of goods sold  0.00.00.00.086.80.00.00.0
Gross profit  0.00.00.0-2.0-45.30.0-11.30.0
            Gross margin     100.0%-109.1% 100.0% 
Selling, general and administrative   [+]13.316.114.814.413.012.511.80.3
Research and development  33.732.853.736.9 25.918.12.7
EBITDA   [+]-46.8-48.8-68.4-53.2    
            EBITDA margin     2686.4%-140.3% 365.0% 
Depreciation and amortization  0.20.10.00.0    
EBIT   [+]-47.0-48.9-68.4-53.2-58.3-38.3-41.3-3.0
            EBIT margin     2687.8%-140.3% 365.0% 
Interest expense, net   [+]2.52.31.71.51.3-0.10.00.0
Other income (expense), net   [+]0.51.25.40.3-1.1-1.9-0.2-0.3
Pre-tax income  -48.9-50.0-64.7-54.4-60.7-40.2-41.5-3.3
Income taxes  -24.10.70.00.10.10.00.00.0
            Tax rate  49.1% 0.0%  0.0%0.0%0.0%
Net income  -24.9-50.7-64.7-54.5-60.8-40.2-41.5-3.3
            Net margin     2752.4%-146.3% 366.4% 
   
Basic EPS   [+]($0.26)($0.53)($0.69)($0.60) ($0.45)($0.65) 
Diluted EPS   [+]($0.26)($0.53)($0.69)($0.60) ($0.45)($0.65) 
   
Shares outstanding (basic)   [+]95.294.994.190.5 89.963.5 
Shares outstanding (diluted)   [+]95.294.994.190.5 89.963.5 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy